Related Experiment Video

Updated: Aug 30, 2026

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease
06:25

Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease

Published on: March 29, 2024

The heregulin/human epidermal growth factor receptor as a new growth factor system in melanoma with multiple ways of

Christophe Stove1, Veronique Stove, Lara Derycke

  • 1Laboratory of Experimental Cancerology, Department of Radiotherapy and Nuclear Medicine, Ghent University Hospital, Ghent, Belgium.

The Journal of Investigative Dermatology
|November 25, 2003
PubMed

Insights

Melanoma cells secrete heregulin, a growth factor that stimulates melanocytes and melanoma cells via human epidermal growth factor receptor (HER) family pathways. Deregulation of HER3 or HER2 receptors can lead to growth factor independence in melanoma.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Melanoma cells release growth factors that influence their proliferation.
  • Heregulin is a ligand for the human epidermal growth factor receptor (HER) family.
  • The role of heregulin and its receptors in melanoma progression is not fully understood.

Purpose of the Study:

  • To identify novel growth factors secreted by melanoma cells.
  • To investigate the role of heregulin and its receptors in melanocyte and melanoma cell growth.
  • To explore the implications of heregulin/HER system deregulation in melanoma.

Main Methods:

  • Screening of conditioned media from melanoma cell lines.
  • Detection of heregulin expression and secretion.
  • Analysis of human epidermal growth factor receptor (HER) family expression (HER2, HER3) in melanocytes and melanoma cells.
  • Assessment of cell proliferation in response to heregulin.

Main Results:

  • Heregulin was identified as a key secreted factor from melanoma cells.
  • Heregulin, including a novel isoform, stimulated melanocyte and melanoma cell growth via autocrine and paracrine mechanisms.
  • HER3 and HER2 were the primary receptors, but overexpression was not observed.
  • Loss of functional HER3 or HER2 rendered cells unresponsive to heregulin, indicating growth factor independence.

Conclusions:

  • The heregulin/HER system is a significant physiological regulator of melanocyte growth.
  • Alterations in HER3 and HER2 expression are implicated in melanoma progression.
  • Deregulation of this pathway contributes to growth factor independence in melanoma cells.

More Related Videos

The Three-Dimensional Human Skin Reconstruct Model: a Tool to Study Normal Skin and Melanoma Progression11:02

The Three-Dimensional Human Skin Reconstruct Model: a Tool to Study Normal Skin and Melanoma Progression

Published on: August 3, 2011

A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...